Shanghai, China

Xiaojuan Qu

This inventor holds 1 USPTO granted patent. Top assignee: Shanghaitech University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaojuan Qu. Retrieved from https://idiyas.com/inventor/xiaojuan-qu-bsrqhl0x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xiaojuan Qu

Introduction

Xiaojuan Qu is a notable inventor based in Shanghai, China. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the creation of compounds that can effectively target and degrade specific proteins associated with tumor growth.

Latest Patents

Xiaojuan Qu holds a patent for an EGFR protein degradant and its anti-tumor application. This invention is described as a bifunctional compound, which may include a pharmaceutically acceptable salt, an isomer, a prodrug, a polymorphic substance, or a solvate thereof. The chemical structural formula of this bifunctional compound is represented as formula I. This compound has the potential to be used for preventing or treating various types of cancers.

Career Highlights

Xiaojuan Qu is affiliated with ShanghaiTech University, where she conducts her research and development activities. Her work has garnered attention for its innovative approach to cancer therapy, showcasing her dedication to advancing medical science.

Collaborations

Xiaojuan Qu collaborates with esteemed colleagues, including Chaowei Ren and Renhong Sun. These partnerships enhance her research efforts and contribute to the development of effective cancer treatments.

Conclusion

Xiaojuan Qu's contributions to the field of cancer treatment through her innovative patent demonstrate her commitment to improving healthcare. Her work exemplifies the impact of scientific research on addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…